financetom
Business
financetom
/
Business
/
Zeni aims to become billion-dollar company in few years
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zeni aims to become billion-dollar company in few years
Aug 18, 2021 11:36 AM

SaaS is the future that is the consensus emerging in Silicon Valley and in India. Zeni, a SaaS-based book keeping and accounting platform, was founded by Swapnil and Snehal Shinde in 2019. The mission was to remove the pain from accounting and make it almost Zen like, hence the name!

Share Market Live

NSE

Before this, the duo founded Mezi in 2015, an artificial intelligence-powered travel assistant platform, which was acquired by American Express for an estimated $125-150 million in 2018.

Their first venture was Dhingana, an Indian on-demand music service platform, founded in 2008, which was acquired by digital music service provider Rdio in 2014.

In an interview to Shereen Bhan, Swapnil Shinde, co-founder & CEO of Zeni, and Snehal Shinde, co-founder & Chief Product Officer of Zeni, said, "Building finance functions is extremely painful and overwhelming. You have to hire too many people like accountant, book keeper, tax expert, and it just keeps getting more complex as you scale the company. So, we wanted to create something that is far more easier for founders to use and that is how Zeni started."

The company aims to hit $1 billion in a few years.

"We intend to hit $1 billion in next couple of years. We need to turbo charge our growth and have few hundred more customers and then probably reach a stage where we are processing more than $1 billion in transactions every single month. Right now we are managing more than $500 million in finances every month across all our customers."

Also Read: Focus on user retention a positive outcome of COVID pandemic, says CleverTap's Sunil Thomas

They said more than 120 startups have signed up with Zeni as of now.

"We have more than 120 startups who have signed up with Zeni. We have close to around 50 employees. Everyone on our team is a full time employee. Also, 50 percent of our current customers have subsidiaries around the world."

Also Read: COVID gave SaaS based companies a chance to thrive and not just survive, says Uniphore's Umesh Sachdeva

Watch video for more.

(Edited by : Bivekananda Biswas)

First Published:Aug 18, 2021 8:36 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
FinVolution Receives $5.3 Million In Financing From SeaBank Philippines
FinVolution Receives $5.3 Million In Financing From SeaBank Philippines
Mar 28, 2024
07:08 AM EDT, 03/28/2024 (MT Newswires) -- FinVolution Group ( FINV ) said Thursday that its Juanhand financial application has entered into an agreement to receive a funding facility worth about 300 million Philippine pesos ($5.3 million) from SeaBank Philippines Bank. The Chinese fintech firm said the agreement will help it expand its international offerings and connect underserved borrowers in...
Reddit Shares Fall Pre-Bell After Insider Sales; Short Sellers Reportedly Swarm Stock
Reddit Shares Fall Pre-Bell After Insider Sales; Short Sellers Reportedly Swarm Stock
Mar 28, 2024
07:12 AM EDT, 03/28/2024 (MT Newswires) -- Reddit's ( RDDT ) recently debuted stock is reportedly drawing short sellers as it fell 5.5% in recent Thursday premarket activity following several insider sales from its senior management. Reddit ( RDDT ) Chief Executive Steve Huffman, Chief Financial Officer Andrew Vollero, Chief Technology Officer Christopher Slowe and Chief Operating Officer Jennifer Wong...
Akebia Therapeutics Shares Jump Pre-Bell on FDA Approval of Anemia Treatment for Chronic Kidney Disease Dialysis Patients
Akebia Therapeutics Shares Jump Pre-Bell on FDA Approval of Anemia Treatment for Chronic Kidney Disease Dialysis Patients
Mar 28, 2024
07:16 AM EDT, 03/28/2024 (MT Newswires) -- Akebia Therapeutics ( AKBA ) said late Wednesday the US Food and Drug Administration has approved its Vafseo tablets for the treatment of anemia due to chronic kidney disease in adults on dialysis for at least three months. Vafseo or vadadustat, a once-daily oral treatment to manage anemia, is now approved in 37...
Atour Lifestyle Q4 Sales Surge; Shares Jump Premarket
Atour Lifestyle Q4 Sales Surge; Shares Jump Premarket
Mar 28, 2024
07:11 AM EDT, 03/28/2024 (MT Newswires) -- Atour Lifestyle ( ATAT ) reported Q4 earnings early Thursday of 1.59 Chinese renminbi ($0.22) per American depositary share. Two analysts polled by Capital IQ expected 1.39 renminbi. Revenue for the quarter that ended Dec. 31 was 1.51 billion renminbi, up from 626.2 million renminbi a year earlier. Three analysts surveyed by Capital...
Copyright 2023-2026 - www.financetom.com All Rights Reserved